Skip to content
Home
Myopia
IMI White Papers
IMI White Papers & Clinical Summaries
IMI Taskforce Interviews
Myopia Infographics
Taskforces
Membership
Sponsors
News
Menu
Home
Myopia
IMI White Papers
IMI White Papers & Clinical Summaries
IMI Taskforce Interviews
Myopia Infographics
Taskforces
Membership
Sponsors
News
QF2541v1 COOPERVISION SEC WHITEPAPERS PART II_2021
QF2541v1 COOPERVISION SEC WHITEPAPERS PART II_2021
By
Rhys Blyth
/
March 11, 2022
Post navigation
←
Previous Media
No citation data has been entered for this IMI Whitepaper